Abstract-When cultured cells are exposed to plasma, the initial acceptors of unesterified cholesterol are small lipid-poor apolipoprotein A-I (apoA-I)-containing high density lipoproteins (HDLs) with pre-␤ electrophoretic mobility. These are converted by lecithin:cholesterol acyltransferase into larger spheroidal cholesteryl ester-rich HDLs with ␣ mobility. To study the determinants of the concentration of small pre-␤ HDLs in tissue fluids, we collected prenodal peripheral lymph from 34 fasted normal men. By crossed immunoelectrophoresis, the concentration of pre-␤ HDLs in lymph averaged 20% of that in plasma. On multiple regression analysis, pre-␤ apoA-I concentration in lymph was directly related to pre-␤ apoA-I concentration in plasma and independently to ␣ apoA-I concentration in lymph. Similar results were obtained when the same apoA-I-containing particles were quantified by size exclusion chromatography. Lymph pre-␤ apoA-I concentration was low in a subject with familial lecithin:cholesterol acyltransferase deficiency, despite a normal plasma pre-␤ apoA-I concentration, but was normal in a subject with familial lipoprotein lipase deficiency. These results suggest that the concentration of small pre-␤ HDLs in human tissue fluids is determined only in part by the transfer of pre-␤ HDLs across capillary endothelium from plasma. 
A polipoprotein A-I (apoA-I) is the principal protein component of plasma HDLs and the cofactor of lecithin:cholesterol acyltransferase (LCAT). 1 The HDLs are a heterogeneous family of lipoproteins that mediate reverse cholesterol transport from tissues. 1, 2 When cultured cells are exposed to plasma, the principal primary acceptors of cellderived unesterified cholesterol (UC) are a minor subclass of small lipid-poor HDLs, whose only protein is apoA-I and which have pre-␤ electrophoretic mobility. [1] [2] [3] [4] These are converted by LCAT into larger cholesteryl ester (CE)-rich spheroidal particles, which have ␣ electrophoretic mobility and constitute the majority of plasma HDLs. 1, 2, 4, 5 The origins of the pre-␤ HDLs are not certain, but similar particles are formed when lipid-free apoA-I recruits phospholipids (PLs) from cultured cells. 6, 7 Lipid-free or lipid-poor apoA-I is released when spheroidal HDLs are remodeled by PL transfer protein, CE transfer protein, or hepatic lipase. 8 -10 There is evidence that pre-␤ HDL concentration is rate limiting for the specific apolipoprotein-mediated component of UC efflux from cells. Thus, when human plasma samples were preincubated, proportional reductions occurred in pre-␤ HDL concentration and cholesterol efflux from fibroblasts. 3 Others have found that cholesterol efflux from hepatoma cells to transgenic rabbit plasma was correlated with pre-␤ HDL concentration. 11 Our knowledge of HDLs and their role in reverse cholesterol transport is derived mostly from studies of plasma. However, most peripheral cells are exposed not to plasma but to tissue fluid. Studies in dogs, 12 sheep, 13 and humans 14 have shown that tissue fluid lipoproteins differ from plasma lipoproteins. These differences reflect the differential transfer of lipoproteins across endothelia and metabolic events in the extravascular space. ApoA-I-containing particles with pre-␤ and ␣ mobilities have been demonstrated in canine 15 and human 16 peripheral lymph. Subclasses with pre-␣ mobility 17 and lipid-free apoA-I 15 have also been reported. However, there is no information on the factors that determine the concentrations of these different of apoA-I-containing particles in tissue fluid.
The difficulties of studying tissue fluid lipoproteins in humans are considerable. Suction blisters provide insufficient fluid and may be misleading, because the increase in capillary permeability must alter its composition. 18 The only reliable matrix is prenodal peripheral lymph. Almost all published data on human peripheral lymph lipoproteins were obtained with the use of a collection procedure (from the foot) that has several major problems: a high failure rate, low flow rates, a short cannulation life, and the need to preinject a dye subcutaneously. To obviate these problems, we have adapted a procedure that uses a larger vessel in the leg. 19 In the present study, we have partially characterized the major electrophoretic and size subclasses of apoA-I-containing particles in human lymph and investigated the factors that determine their concentrations.
Methods

Subjects
There were 36 subjects: 34 healthy males, 1 male with familial LCAT deficiency, and 1 male with familial lipoprotein lipase (LPL) deficiency (Table 1) . Subjects were excluded if they had renal, hepatic, endocrine, or cardiovascular disease or if they were on a diet (other than for LPL deficiency) or medication. In the subject with LCAT deficiency, plasma LCAT activity, assayed by use of apoA-I/lecithin/[ 14 C]cholesterol proteoliposomes, was 1.3 nmol ⅐ mL Ϫ1 ⅐ h Ϫ1 (normal, 39.4 to 112 nmol ⅐ mL Ϫ1 ⅐ h Ϫ1 ), the cholesterol esterification rate in vitro was 6.5 nmol ⅐ mL Ϫ1 ⅐ h Ϫ1 (normal, 18.0 to 31.4 nmol ⅐ mL Ϫ1 ⅐ h Ϫ1 ), and the plasma UC/CE ratio was 4.47 (normal, 0.39 to 0.55). The subject with LPL deficiency, described elsewhere, 20 had been on a low fat diet for several years. The study was approved by an ethics committee. All subjects gave informed consent.
Clinical Procedures
Cannulations were performed between 8:00 and 11:00 AM under sterile conditions. The subjects had fasted overnight but were allowed fat-free drinks. One leg was shaved to 20 cm above the ankle, and the skin was sterilized (0.05% chlorhexidine). An area of skin (Ϸ4 cm 2 ) 4 to 8 cm above the ankle over the anteromedial aspect of the tibia was anesthetized with 2% lignocaine in adrenaline (1:100 000). A 15-to 20-mm horizontal incision was made in the center of this area. Under an operating microscope (model M650, Wild Heerbrugg), the subcutaneous lymph vessels were dissected, and 1 was selected for cannulation. A second incision (Ϸ3 mm wide) was made Ϸ10 mm above the first, through which a cannula (Intramedic polyethylene tubing PE-60, catalogue No. 427416, Becton Dickinson & Co; ID 0.76 mm, OD 1.22 mm) was passed into the wound. This had been tapered at 1 end, siliconized with Sigmacote (Sigma Chemical Co), sterilized in 70% (vol/vol) ethanol for 24 hours, and flushed with sterile 0.15 mmol/L NaCl. The lymph vessel was ligated proximally with silk (Mersilk, 5/0) and opened with capsulotomy scissors. The first valve distal to the opening was destroyed with the use of curved blunt forceps. The cannula was inserted for 5 to 10 mm (toward the foot) and secured with a silk ligature (Mersilk, 5/0). The skin wound was then closed with 2 sutures (Prolene, 3/0). The other (untapered) end of the cannula was passed into a 2-mL screw-topped polypropylene cryovial (Nunc A/S) containing 2 mg Na 2 EDTA. A gauze dressing was applied, and the cannula and collection tube were secured with tape. Lymph was collected for 3 to 6 hours, during which time the subject was ambulatory and given a light fat-free meal and water. A blood sample was taken from an antecubital vein into Na 2 EDTA (final concentration 1 mg/mL).
Laboratory Procedures
Blood and lymph samples were centrifuged (1500g for 15 minutes at 4°C), and the supernatants were transferred to polypropylene tubes. Lymph volumes were determined by weighing. In all analyses, plasma-lymph pairs from the same subject were processed together. All assays were performed in duplicate.
Lipids and Apolipoproteins
Total cholesterol, total triglycerides (TGs), UC, and total cholinecontaining PLs were quantified by use of commercial enzymes (Sigma) in a microtiter plate spectrophotometer. 21 21 The primary antisera were goat polyclonal IgGs against delipidated human apolipoproteins (International Immunology Corp). In the radioimmunoassays, the precipitating antibody was donkey anti-goat IgG (Chemicon). Radioiodinated tracers were prepared with the use of delipidated human apolipoproteins or LDL (density 1.020 to 1.055 g/mL). Radioactivity was quantified to Յ0.1% error. All assays were standardized with the use of Precinorm L.
Nonlipoprotein Proteins
Several proteins were assayed to examine the general relationship of molecular weight to the lymph/plasma (L/P) concentration ratio. ␣ 1 -Acid glycoprotein (38 kDa), ␣ 1 -antitrypsin (54 kDa), albumin (67 kDa), transferrin (76 kDa), complement C3 (180 kDa), and ␣ 2 -macroglobulin (750 kDa) were quantified by immunoelectrophoresis with the use of polyclonal antisera (International Immunology Corp).
Preparative Electrophoresis
In 4 subjects, the distribution of apoA-I, apoA-II, apoB, and lipids among subclasses of lipoproteins isolated by preparative electrophoresis was studied. Samples (500 L) were electrophoresed at 2°C to 4°C in 18 cmϫ20 cmϫ2 mm-thick slab gels composed of 1% (wt/vol) low electroendosmosis agarose (without albumin) for 3 to 4 hours at 150 V in a barbital/EDTA buffer system (50 mmol/L barbital, 20 mmol/L barbituric acid, and 1 mmol/L Na 2 EDTA, pH 8.6) by use of a vertical submerged electrophoresis chamber (model GE-2/4 LS, Pharmacia LKB). Plasma samples were diluted 10-fold in electrophoresis buffer. Paired lymph and plasma samples were processed in a single gel. After electrophoresis, the gels were sliced transversely into 22 strips, extending from the origin to Ϸ125% of the migration of the bromophenol blue dye front. Lipoproteins were recovered from each strip by ultracentrifugation (15 minutes at 4°C, 50 000 rpm) in a Beckman 50.4Ti rotor. Recoveries of apoA-I and cholesterol were Ͼ95%. Lipids and apolipoproteins were assayed as described above.
Crossed Immunoelectrophoresis
ApoA-I concentrations in pre-␤ and ␣ migrating particles were quantified by crossed immunoelectrophoresis. 21 Lymph-plasma pairs were run in the same gel. Lymph was run undiluted, but plasma was diluted 1:4 with electrophoresis buffer, so as to provide similar masses of apoA-I. The first dimension was through a 1% (wt/vol) 
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low electroendosmosis agarose slab gel (SeaKem LE, FMC Bioproducts) at 30 V/cm for 2 hours at 4°C with the use of 63 mmol/L Tris, 27 mmol/L tricine, 1 mmol/L calcium lactate, and 3 mmol/L sodium azide (pH 8.6) as electrolytes. The second dimension was through the same gel impregnated with 0.5% (vol/vol) goat polyclonal antihuman apoA-I serum (INCStar Corp), 0.2% (vol/vol) Tween 20, and 3% (wt/vol) polyethylene glycol 8000, at 15 V/cm for 4 to 6 hours at 4°C with use of the same buffer. Electrophoresis was always run to equilibrium. After they were soaked in 150 mmol/L NaCl for 18 hours at ambient temperature, antigen-antibody complexes were stained for 1 hour with 0.5% (wt/vol) Coomassie blue R250 in ethanol/acetic acid/water (9:2:9 [vol/vol]), and the relative proportions (area under the curve) of apoA-I in pre-␤ and ␣ regions were quantified. Absolute apoA-I concentrations in the subclasses were calculated by reference to the total apoA-I in the sample. The intra-assay coefficient of variation for pre-␤ apoA-I concentration was 11% (nϭ8, mean 5 mg/dL).
Size Exclusion Chromatography
In 18 normal subjects and the LPL-deficient subject, high-performance size-exclusion chromatography (HP-SEC) was used to separate apoA-I-containing particles into 3 size subclasses. Aliquots (50 L) of 4-fold diluted plasma or undiluted lymph were passed through Superdex 200 and Superdex 75 columns (HR 10/30, Pharmacia) in series at ambient temperature. 22 A degassed solution of 50 mmol/L Tris-HCl (pH 7.4), 150 mmol/L NaCl, 0.1% (wt/vol) Na 2 EDTA, and 0.1% (wt/vol) sodium azide was used as an eluant (0.75 mL/min). After excluding the void volume, 200 L fractions were collected and assayed for apoA-I. Recoveries were Ͼ90%. Particle sizes were determined with the use of a protein mixture (catalogue No. MW-GF-1000, Sigma; molecular mass 29 to 700 kDa). This procedure separates apoA-I-containing particles in plasma into a major population of 70 to 500 kDa (fractions 16 to 41), a minor population of larger particles (Ͼ500 kDa, fractions 11 to 15), and a minor population of small particles (40 to 60 kDa, fractions 42 to 56). 21, 22 The major population is composed of CE-rich spheroidal ␣ HDLs. The small particles appear to be a mixture of lipid-poor apoA-I (pre-␤ 1 HDLs) and lipid-free apoA-I dimers. 22
Statistical Analyses
Data from plasma and lymph samples from the same subjects were compared statistically by the Student paired t test. Associations were examined by the Pearson coefficient of linear correlation. A value of PϽ0.05 was considered to be statistically significant.
Results
The total volume of lymph varied from 0.10 to 8.2 mL (meanϮSEM, 1.71Ϯ0.28 mL). Flow rates averaged 0.68Ϯ0.14 mL/h (range 0.03 to 4.09 mL/h). In the normal subjects, total apoA-I concentration in lymph averaged 21.4Ϯ1.3% of that in plasma. Concentrations in the 2 matrices had a weak positive association (rϭ0.31, Pϭ0.08). In 3 subjects, the ratio of apoA-I mass in HDLs with and without apoA-II (determined by immunoprecipitation of apoA-II) was similar in lymph and plasma (2.43Ϯ0.34 versus 2.17Ϯ0.09).
Preparative Electrophoresis
In both matrices, apoA-I migrated as a minor pre-␤ band and a major ␣ band, whereas apoA-II migrated only as an ␣ band (Figure 1 ). The apoA-I and apoA-II of ␣ particles migrated slightly faster in lymph than in plasma. ApoB migrated mostly as a ␤ band in lymph and plasma, with no difference in mobility between the matrices. All lipids eluted in 2 peaks corresponding to the major ␣ and ␤ regions. Lymph contained relatively more of each lipid in the ␣ region and, within this region, relatively more in the faster migrating particles.
Crossed Immunoelectrophoresis
No major differences were observed between the 2 matrices in the mobilities of the pre-␤ or ␣ peaks (Figure 2 ). Concentrations of pre-␤ and ␣ migrating apoA-I are summarized in Table 2 ; the mean pre-␤/␣ ratio in lymph was not significantly different from that in plasma. The concentration of pre-␤ apoA-I in lymph was positively correlated with that in plasma ( Figure 3 ). The correlation between the ␣ apoA-I concentration in lymph and that in plasma was not statistically significant ( Figure 3 ). Within both matrices, there were significant positive correlations between the pre-␤ apoA-I and ␣ apoA-I concentrations ( Figure 3 ).
Size Exclusion Chromatography
Typical size exclusion profiles of apoA-I appear in Figure 4 . The results in normal plasma were as previously described. 21, 22 The size distributions of the small particles were similar in the 2 matrices. However, the distribution of apoA-I within the major population of particles was shifted toward the larger species and often also (to a lesser degree) toward the smaller species, in lymph compared with plasma. In lymph, the concentration of apoA-I in the small particles but not in the major population of particles was significantly positively correlated with its counterpart in plasma ( Figure 5 ). Within both matrices, the concentration of apoA-I in the small particles was positively correlated with that in the major population of particles ( Figure 5 ). The ratio of apoA-I in the small particles to that in the major population was similar in lymph and plasma (Table 2) .
Nonlipoprotein Proteins
In normal subjects, the L/P ratios of other proteins were inversely related to their molecular masses ( Figure 6 ). The mean L/P ratio of apoA-I in large ␣ HDLs was close to that predicted for a macromolecule of 200 kDa (the approximate mean molecular mass of most plasma HDLs). The mean L/P ratio of apoA-I in small pre-␤ HDLs was lower than expected for particles of 40 to 60 kDa.
Familial LPL Deficiency
In plasma and lymph from the LPL-deficient subject, the concentrations of pre-␤ and ␣ migrating apoA-I were within the normal ranges (Figure 3) . Concordant results were obtained by HP-SEC ( Figure 5 ).
Familial LCAT Deficiency
The LCAT-deficient subject had a normal plasma pre-␤ apoA-I concentration but extremely low concentrations of ␣ apoA-I in plasma and of pre-␤ apoA-I and ␣ apoA-I in lymph ( Figure 3 ). Insufficient lymph was available from this subject for HP-SEC.
Discussion
The present study is the first to examine the associations between the concentrations of apoA-I in the major electrophoretic and size subclasses of particles in human peripheral lymph and plasma. Reichl and coworkers 16, 23, 24 characterized the distribution of apoA-I in human foot lymph by gel filtration, gradient gel electrophoresis, and starch block electrophoresis. However, because those studies were mostly semiquantitative and because each included only 3 to 6 subjects, they provided no information on the relationships of the different subclasses with each other or with their counterparts in plasma.
The vessel that we cannulated collects lymph from skin and subcutaneous tissues. 18 In animals, the protein composition of subcutaneous lymph closely resembles that of local tissue fluid collected by micropuncture or by insertion of wicks or capsules. [25] [26] [27] The dynamics of fluid flow in the interstitium favor the lymphatic over the venous capillary route for the return of macromolecules to plasma. 18 Although regional differences in the lipoproteins of peripheral lymph have been described in animals, these have not been large. 28, 29 Therefore, our data are probably representative of most peripheral tissue fluids in humans. However, because all lymph was collected during the morning after an overnight Values are meanϮSEM. Those for the HP-SEC subclasses were obtained by summing the masses of apoA-I in fractions 42-56 (small particles) and 16 -41 (major population of particles); see Figure 4 . In 14 of the subjects, samples were subjected to HP-SEC and crossed immunoelectrophoresis. Results for apoA-I in the population of small particles by HP-SEC were in good agreement with those for pre-␤ apoA-I, and those for apoA-I in the major population of particles by HP-SEC agreed well with those for ␣ migrating apoA-I. Regression equations were as follows (mg/dL): for plasma, small apoA-Iϭ0.80 ⅐ pre-␤ apoA-Iϩ0.69 (r 2 ϭ0.98) and major apoA-Iϭ1.02 ⅐ ␣ apoA-IϪ1.01 (r 2 ϭ0.99); for lymph, small apoA-Iϭ0.67 ⅐ pre-␤ apoA-Iϩ0.28 (r 2 ϭ0.71) and major apoA-Iϭ1.02 ⅐ ␣ apoA-IϪ0.20 (r 2 ϭ0.98).
fast, our results cannot be extrapolated to other times of the day or to the nonfasted state. The lipids and apolipoproteins of peripheral lymph lipoproteins are derived largely from plasma. It is probable that lipoproteins cross endothelia mostly by filtration, 30, 31 although transcytosis may also contribute. 32 Filtration favors small over large particles. 30, 31, 33 Once outside the plasma compartment, the smallest particles will have the greatest probability of interacting with peripheral cells because of the sieving effect of the extracellular matrix. 34 By preparative electrophoresis, we found that (as in plasma) the pre-␤ HDLs of lymph were devoid of apoA-II. Because of the proximity of the pre-␤ band to the apo B-containing lipoproteins, we could not accurately determine the lipid content of the former. Within the ␣ migrating species, apoA-I, UC, CE, and PLs were shifted toward the more negatively charged particles relative to their profiles in plasma. These results confirm and extend the observations of Reichl et al. 16 Possible explanations for this charge difference include differences in apoA-I conformation and PL composition.
By crossed immunoelectrophoresis, pre-␤ apoA-I concentration in lymph averaged Ϸ20% of that in plasma, and there was no difference between the matrices in the pre-␤/␣ ratio. Lymph pre-␤ apoA-I concentration was positively correlated with lymph ␣ apoA-I and plasma pre-␤ apoA-I concentrations but was not significantly correlated with plasma ␣ apoA-I concentration. Although we failed to identify any apoA-I with pre-␣ mobility, as reported in canine lymph, 17 this may have reflected the lower resolving power of our procedure.
In view of the likely importance of the small pre-␤ particles as acceptors of cell-derived UC in tissue fluids, we examined by multiple linear regression the independent effects of the other fractions on lymph pre-␤ apoA-I concentration. This showed that lymph pre-␤ apoA-I was independently positively related to the plasma pre-␤ apoA-I and lymph ␣ apoA-I concentrations (PϽ0.0005 for each coefficient) as follows: lymph pre-␤ apoA-Iϭ0.007ϩ(0.075 ⅐ plasma pre-␤ apoA-I)ϩ(0.042 ⅐ lymph ␣ apoA-I). Changes of 1 SD in the plasma pre-␤ and lymph ␣ apoA-I concentrations were associated with changes in lymph pre-␤ apoA-I of 0.53 and 0.51 SD, respectively. Fifty-eight percent of the interindividual variance in lymph pre-␤ apoA-I concentration could be explained in this way (PϽ0.0001).
Our HP-SEC results showed that the population of small apoA-I-containing particles, previously shown in plasma to have pre-␤ electrophoretic mobility, 22 had the same size profile in lymph as in plasma. The distribution of apoA-I within the major population, previously shown to be CE-rich ␣ HDLs, 22 was shifted toward larger particles in lymph. This accords with reports that canine peripheral lymph, 35 sheep lung lymph, 13 and human foot lymph 16, 23 are enriched in large HDLs.
When we examined the correlations between the concentrations of apoA-I in the 2 principal size subpopulations in lymph and plasma, the outcome was analogous to that obtained for apoA-I in pre-␤ and ␣ migrating species. Multiple regression analysis also yielded analogous results: the apoA-I concentration in the small particles of lymph was positively related to that in the small particles of plasma and independently to that in the large particles of lymph (not shown). Thus, in normal fasted humans, the concentration of small pre-␤ HDLs in peripheral tissue fluid appears to be determined not only by the concentration of pre-␤ HDLs in plasma, presumably reflecting their transport across endothelium, but also by the concentration of spheroidal ␣ HDLs in the tissue fluid.
The positive association of lymph pre-␤ apoA-I with lymph ␣ apoA-I probably reflects local production of the former particles from the latter particles in tissue fluid rather than interconversion in the opposite direction. First, we have found that when lymph is incubated at 37°C in vitro, pre-␤ apoA-I concentrations increase without the initial decrease that invariably occurs when normal plasma is incubated. [3] [4] [5] 36 Second, LCAT activity, which catalyzes the conversion of pre-␤ HDLs to CE-rich ␣ HDLs, 4,5 appears to be very low in tissue fluid. 37, 38 We have confirmed that human lymph has an extremely low cholesterol esterification rate in vitro (M.N.N. et al, unpublished data, 1999). In the present study, we found in 3 subjects that the UC/CE and pre-␤ apoA-I/␣ apoA-I ratios in samples of lymph collected at ambient temperature were identical to those in samples collected from the same vessels into tubes kept at 0°C to 4°C (data not shown).
Thus, our results support the notion that extravascular remodeling of spheroidal HDLs may play an important role in reverse cholesterol transport by generating small partially lipidated apoA-I-containing particles with high affinity for UC in the vicinity of peripheral cells. This might involve the release of lipid-free apoA-I from spheroidal HDLs, followed by the recruitment of PLs from cell membranes by the apoA-I. 6, 7 Further work is in progress in our laboratory into the mechanism of production of small pre-␤ HDLs in human lymph.
In the subject with LPL deficiency, the concentration of apoA-I in small pre-␤ HDLs in lymph did not differ greatly Figure 5 . Correlations between the total apoA-I concentrations in the population of small particles (fractions 42 to 56) and in the major population of particles (fractions 16 to 41) after fractionation of lymph and plasma from normal subjects by HP-SEC (OE). The total apoA-I in each population was calculated by summing the proportions of apoA-I in their component fractions (see Figure 4 ) and multiplying the result by the total apoA-I concentration (determined directly). Results obtained in the subject with LPL deficiency (‚) are also shown. The correlation coefficients are for the normal subjects. from that predicted by the concentrations of pre-␤ apoA-I in plasma and ␣ apoA-I in lymph (based on the regression equation in normal subjects). This suggests that neither the fractional rate of transfer of pre-␤ HDLs from plasma across endothelium nor their generation in tissue fluids from ␣ HDLs is greatly influenced by the lipolysis of TG-rich lipoproteins at the blood-endothelium interface.
The L/P ratio of pre-␤ apoA-I by crossed immunoelectrophoresis was essentially identical to the L/P ratio of ␣ apoA-I. Likewise, the L/P ratio of apoA-I in small particles by HP-SEC was similar to the L/P ratio of apoA-I in the major population of particles. This is of interest, because one would expect the pre-␤ HDLs, by virtue of their smaller size, to cross endothelium from plasma more readily than ␣ HDLs, giving them a greater L/P ratio. 30, 31 When we measured the L/P ratios of several nonlipoprotein proteins of different molecular masses, the L/P ratio of pre-␤ apoA-I was lower than expected for particles of 40 to 60 kDa. In contrast, the L/P ratio of ␣ apoA-I was as expected for a macromolecule of Ϸ200 kDa average molecular mass. For reasons already discussed, the lower than expected pre-␤ apoA-I concentration is unlikely to have been a consequence of LCATmediated conversion of pre-␤ HDLs to ␣ HDLs either in vivo or in the collection tube. This suggests that there are metabolic factors in peripheral tissues that either degrade pre-␤ HDLs or convert them into other particles by an LCATindependent mechanism. Theoretically, these might include catabolism by cells, although tissue culture studies have indicated that this is unlikely to be quantitatively significant. 39 Because pre-␤ HDLs are more susceptible to proteolysis than are other HDLs, 40 they might be degraded by enzymes released into tissue fluid, 41, 42 although no apoA-I fragments were detected in our HP-SEC fractions of lymph. A third possibility is that some small pre-␤ HDLs are converted in tissue fluid into larger discoidal species that are incompletely resolved by our laboratory procedures, as a consequence of uptake of cell-derived PL and UC. 2, 13, 35, 38 
